Charles Schwab Investment Management Inc. Increases Holdings in National Research Co. (NASDAQ:NRC)

Charles Schwab Investment Management Inc. raised its holdings in National Research Co. (NASDAQ:NRC) by 0.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 124,711 shares of the company’s stock after purchasing an additional 970 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.53% of National Research worth $2,200,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of NRC. Geode Capital Management LLC increased its holdings in National Research by 3.2% during the 3rd quarter. Geode Capital Management LLC now owns 420,733 shares of the company’s stock valued at $9,619,000 after acquiring an additional 13,039 shares in the last quarter. State Street Corp grew its stake in National Research by 4.0% in the third quarter. State Street Corp now owns 363,438 shares of the company’s stock worth $8,351,000 after purchasing an additional 14,144 shares in the last quarter. QV Investors Inc. grew its position in shares of National Research by 4.5% during the 4th quarter. QV Investors Inc. now owns 354,360 shares of the company’s stock valued at $6,251,000 after buying an additional 15,370 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of National Research by 88.5% in the 4th quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company’s stock worth $3,832,000 after acquiring an additional 101,957 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC bought a new stake in shares of National Research during the 3rd quarter worth about $3,158,000. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Stock Performance

Shares of NRC opened at $12.91 on Friday. The firm’s 50 day moving average is $15.90 and its 200-day moving average is $18.06. The stock has a market capitalization of $296.23 million, a P/E ratio of 12.30 and a beta of 0.47. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. National Research Co. has a 12-month low of $12.88 and a 12-month high of $39.98.

National Research (NASDAQ:NRC) last released its quarterly earnings results on Monday, January 27th. The company reported $0.28 earnings per share (EPS) for the quarter. National Research had a net margin of 17.32% and a return on equity of 66.52%.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.72%. The ex-dividend date is Friday, March 28th. National Research’s dividend payout ratio (DPR) is presently 45.71%.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.